STRO

SUTRO BIOPHARMA INC

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary

SUTRO BIOPHARMA INC (STRO) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$26.30M; the largest are Izzy Englander, Steven Cohen, Ken Griffin. This quarter: 1 added, 3 trimmed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.

Attention · MediumThis quarter · Cooling

Common-stock holders4

Congress trades0

Price$16.03vs quarter-end-51.72%

Sectors0

This quarter's moves

New0

Added1

Trimmed / sold3

Top holder

Izzy Englander

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Investor	Period	Value	Shares	% of portfolio	Action

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.